These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33709333)

  • 1. Evaluating the use of pharmacological stress agents during single-photon emission computed tomography myocardial perfusion imaging tests after inadequate exercise stress test.
    Yang H; Faust E; Gao E; Sethi S; Kitt TM; Kristy RM; Spalding JR; Xu Y
    J Nucl Cardiol; 2022 Aug; 29(4):1788-1795. PubMed ID: 33709333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine and dipyridamole.
    Friedman M; Spalding J; Kothari S; Wu Y; Gatt E; Boulanger L
    J Med Econ; 2013; 16(4):449-60. PubMed ID: 23363331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient- and clinician-reported satisfaction with pharmacological stress agents for single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI).
    Hudgens S; Breeze J; Spalding J
    J Med Econ; 2013; 16(6):828-34. PubMed ID: 23614479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A strategy of symptom-limited exercise with regadenoson-as-needed for stress myocardial perfusion imaging: a randomized controlled trial.
    Parker MW; Morales DC; Slim HB; Ahlberg AW; Katten DM; Cyr G; Mathur S; Ardestani A; Barmpouletos D; Iyah GS; Borer SM; Heller GV
    J Nucl Cardiol; 2013 Apr; 20(2):185-96. PubMed ID: 23188626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regadenoson as a new stress agent in myocardial perfusion imaging. Initial experience in The Netherlands].
    Jager PL; Buiting M; Mouden M; Oostdijk AH; Timmer J; Knollema S
    Rev Esp Med Nucl Imagen Mol; 2014; 33(6):346-51. PubMed ID: 24862658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An assessment of the safety, hemodynamic response, and diagnostic accuracy of commonly used vasodilator stressors in patients with severe aortic stenosis.
    Hussain N; Chaudhry W; Ahlberg AW; Amara RS; Elfar A; Parker MW; Savino JA; Titano R; Henzlova MJ; Duvall WL
    J Nucl Cardiol; 2017 Aug; 24(4):1200-1213. PubMed ID: 26979307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regadenoson-stress myocardial CT perfusion and single-photon emission CT: rationale, design, and acquisition methods of a prospective, multicenter, multivendor comparison.
    Cury RC; Kitt TM; Feaheny K; Akin J; George RT
    J Cardiovasc Comput Tomogr; 2014; 8(1):2-12. PubMed ID: 24314823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EXERRT trial: "EXErcise to Regadenoson in Recovery Trial": A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exercise for myocardial perfusion imaging using a SPECT protocol.
    Thomas GS; Cullom SJ; Kitt TM; Feaheny KM; Ananthasubramaniam K; Gropler RJ; Jain D; Thompson RC
    J Nucl Cardiol; 2017 Jun; 24(3):788-802. PubMed ID: 28224449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of regimented aminophylline use on extracardiac radioisotope activity in patients undergoing regadenoson stress SPECT myocardial perfusion imaging: a substudy of the ASSUAGE trial.
    Ballany W; Mansour K; Morales Demori R; Al-Amoodi M; Doukky R
    J Nucl Cardiol; 2014 Jun; 21(3):496-502. PubMed ID: 24519563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regadenoson versus dipyridamole: Evaluation of stress myocardial blood flow response on a CZT-SPECT camera.
    Brana Q; Thibault F; Courtehoux M; Metrard G; Ribeiro MJ; Angoulvant D; Bailly M
    J Nucl Cardiol; 2022 Feb; 29(1):113-122. PubMed ID: 32651801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regadenoson versus Dipyridamole: A Comparison of the Frequency of Adverse Events in Patients Undergoing Myocardial Perfusion Imaging.
    Amer KA; Hurren JR; Edwin SB; Cohen G
    Pharmacotherapy; 2017 Jun; 37(6):657-661. PubMed ID: 28475259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regadenoson: a focused update.
    Ghimire G; Hage FG; Heo J; Iskandrian AE
    J Nucl Cardiol; 2013 Apr; 20(2):284-8. PubMed ID: 23229649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease.
    Doukky R; Fughhi I; Campagnoli T; Wassouf M; Ali A
    J Nucl Cardiol; 2017 Feb; 24(1):112-118. PubMed ID: 26582040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and feasibility of adjunctive regadenoson injection at peak exercise during exercise myocardial perfusion imaging: The Both Exercise and Regadenoson Stress Test (BERST) trial.
    Ross MI; Wu E; Wilkins JT; Gupta D; Shen S; Aulwes D; Montero K; Holly TA
    J Nucl Cardiol; 2013 Apr; 20(2):197-204. PubMed ID: 23404232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial perfusion SPECT imaging in patients with myocardial bridging.
    Vallejo E; Morales M; Sánchez I; Sánchez G; Alburez JC; Bialostozky D
    J Nucl Cardiol; 2005; 12(3):318-23. PubMed ID: 15944537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial.
    Mahmarian JJ; Cerqueira MD; Iskandrian AE; Bateman TM; Thomas GS; Hendel RC; Moye LA; Olmsted AW
    JACC Cardiovasc Imaging; 2009 Aug; 2(8):959-68. PubMed ID: 19679284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A useful and easy to develop combined stress test for myocardial perfusion imaging: Regadenoson and isometric exercise, preliminary results.
    Janvier L; Pinaquy J; Douard H; Karcher G; Bordenave L
    J Nucl Cardiol; 2017 Feb; 24(1):34-40. PubMed ID: 26542990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of transient ischemic dilation with regadenoson myocardial perfusion imaging.
    Lester D; El-Hajj S; Farag AA; Bhambhvani P; Tauxe L; Heo J; Iskandrian AE; Hage FG
    J Nucl Cardiol; 2016 Oct; 23(5):1147-1155. PubMed ID: 26490267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: a quantitative analysis from the ADVANCE MPI trials.
    Mahmarian JJ; Peterson LE; Xu J; Cerqueira MD; Iskandrian AE; Bateman TM; Thomas GS; Nabi F
    J Nucl Cardiol; 2015 Apr; 22(2):248-61. PubMed ID: 25287737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification with vasodilator stress SPECT myocardial perfusion imaging in patients with elevated cardiac biomarkers.
    Gowdar S; Ahlberg AW; Rai M; Perucki WH; Felpel KD; Savino JA; Alter EL; Henzlova MJ; Duvall WL
    J Nucl Cardiol; 2020 Dec; 27(6):2320-2331. PubMed ID: 30815834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.